IN-SITU HYBRIDIZATION AND DIRECT FLUORESCENCE ANTIBODIES FOR THE DETECTION OF CHLAMYDIA-TRACHOMATIS IN SYNOVIAL TISSUE FROM PATIENTS WITH REACTIVE ARTHRITIS
J. Berlau et al., IN-SITU HYBRIDIZATION AND DIRECT FLUORESCENCE ANTIBODIES FOR THE DETECTION OF CHLAMYDIA-TRACHOMATIS IN SYNOVIAL TISSUE FROM PATIENTS WITH REACTIVE ARTHRITIS, Journal of Clinical Pathology, 51(11), 1998, pp. 803-806
Background-Chlamydia trachomatis is associated with Reiter's syndrome
and reactive arthritis but the form in which the organism survives in
synovial cells is unclear. Aim-To compare in situ hybridisation with d
irect fluorescence in the detection of inapparent chlamydial infection
in synovial tissue. Methods-Synovial tissue from four patients with r
eactive arthritis patients was examined using biotin labelled probes f
or chlamydial DNA and fluorescein isothiocyanate (FITC) labelled monoc
lonal antibodies against the major outer membrane protein. Results-In
two of the four patients, evidence of chlamydial infections was detect
ed by in situ hybridisation in parallel sections but not with FITC lab
elled monoclonal antibodies. Conclusions-Detection of chlamydial DNA b
y in situ DNA hybridisation may be a better way to identify chlamydial
infection in synovial tissue than phenotype targeting with FITC conju
gated antibodies, which is used as a standard procedure for screening
clinical specimens for chlamydia.